Dr Reddy’s gets FDA nod for ‘Tosymra’ migraine nasal spray Industry-Economic Times — January 28, 2019 comments off The drug maker said the audit of its API manufacturing plant at Miryalaguda in Telangana, by the US FDA, has been completed.
The drug maker said the audit of its API manufacturing plant at Miryalaguda in Telangana, by the US FDA, has been completed.